Literature DB >> 7477984

A prospective evaluation of cognitive decline in early Huntington's disease: functional and radiographic correlates.

K A Bamford1, E D Caine, D K Kido, C Cox, I Shoulson.   

Abstract

We examined prospectively the relationship between progressive disability in Huntington's disease (HD) and concomitant alterations in neuropsychological functioning and brain imaging indices in a cohort of 60 patients who were enrolled and followed for 30 to 42 months in a controlled clinical trial. Standardized measures of functional capacity and neuropsychological performance were collected, and CT was performed, at regular intervals every 6 to 12 months. Psychomotor skills showed the most significant and consistent decline among the cognitive functions assessed. Memory disturbances were already present at the time of enrollment, but memory did not deteriorate until patients reached advanced stages. Other cognitive operations, such as visual construction and semantic knowledge, manifested small and variable changes over time. CT indices of striatal atrophy correlated only with changes in psychomotor function, while the CT index of frontal atrophy weakly predicted memory and semantic knowledge scores at 42 months. These results confirmed earlier cross-sectional findings and extended our knowledge of the evolution of cognitive dysfunction in HD.

Entities:  

Mesh:

Year:  1995        PMID: 7477984     DOI: 10.1212/wnl.45.10.1867

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

1.  Huntington's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

Review 2.  Brain imaging and cognitive dysfunctions in Huntington's disease.

Authors:  Alonso Montoya; Bruce H Price; Matthew Menear; Martin Lepage
Journal:  J Psychiatry Neurosci       Date:  2006-01       Impact factor: 6.186

Review 3.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

4.  Cognitive and functional decline in Huntington's disease: dementia criteria revisited.

Authors:  Guerry M Peavy; Mark W Jacobson; Jody L Goldstein; Joanne M Hamilton; Amy Kane; Anthony C Gamst; Stephanie L Lessig; J C Lee; Jody Corey-Bloom
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

5.  Treatment of huntington disease.

Authors:  Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

6.  Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.

Authors:  Patrizia Popoli; Annita Pintor; Maria Rosaria Domenici; Claudio Frank; Maria Teresa Tebano; Antonella Pèzzola; Laura Scarchilli; Davide Quarta; Rosaria Reggio; Fiorella Malchiodi-Albedi; Mario Falchi; Marino Massotti
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

Review 7.  Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases.

Authors:  Mahesh Ramalingam; Sung-Jin Kim
Journal:  J Neural Transm (Vienna)       Date:  2012-01-04       Impact factor: 3.575

8.  Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors:  Leigh J Beglinger; Kevin Duff; Jessica Allison; Danielle Theriault; Justin J F O'Rourke; Anne Leserman; Jane S Paulsen
Journal:  J Clin Exp Neuropsychol       Date:  2009-10-29       Impact factor: 2.475

9.  Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.

Authors:  Jurgen Lemiere; Marleen Decruyenaere; Gery Evers-Kiebooms; Erik Vandenbussche; Rene Dom
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

Review 10.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.

Authors:  S Klöppel; S M Henley; N Z Hobbs; R C Wolf; J Kassubek; S J Tabrizi; R S J Frackowiak
Journal:  Neuroscience       Date:  2009-01-29       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.